Information from the latest Hong Kong Stock Exchange filings reveals that on June 4th, Board Chairman Wu Yifang purchased an additional 20,000 shares of EVEREST MED (01952).
The transaction was executed at HK$28.8 per share, amounting to a total consideration of HK$576,000.
Following this acquisition, his total shareholding has increased to approximately 2.1602 million shares, representing a stake of about 0.61% in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments